Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and …
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
Numab Therapeutics AG (“Numab”) and Ono Pharmaceutical Co., Ltd. (“Ono”) today announced a global research, development …
European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies
A ground-breaking research collaboration between European Wellness Biomedical Group (EWBG), through its subsidiaries European Wellness …
